AK
Aditya Kulkarni
About Aditya Kulkarni
Data last updated:
Aditya Kulkarni is a Managing Director at Aten Porus Lifesciences Private Limited (since 2013), Managing Director at Aten Biotech Private Limited (since 2013) and Director at Avammune Lifesciences Private Limited (since 2024), and holds 1 more current directorship. The companies operate in Pharma, Agriculture and Paper. The 2 current companies with reported revenue have a combined latest revenue of ₹2.98 Cr; the largest is Aten Porus Lifesciences Private Limited at ₹2.69 Cr (FY 2024). Earlier, Aditya Kulkarni was a Director at Straximm Therapeutics Private Limited (from 2018).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 25 Jul 2013 | 2013 | ₹2.69 Cr (FY 2024) | Active | |
| Managing Director | 01 Jun 2013 | 2013 | ₹28.9 Lakh (FY 2023) | Active | |
| Director | 08 Nov 2024 | 2024 | Active | ||
| Designated Partner | 20 Dec 2017 | 2017 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 20 Apr 2018 | 2018 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Aditya Kulkarni
| Name | DIN | Company | Designation |
|---|---|---|---|
| Arun Bellandur Papaiah | 06555770 | Aten Porus Lifesciences Private Limited , Aten Biotech Private Limited and 2 more | Managing Director |
| Namala Srinivasan | 00747454 | Aten Porus Lifesciences Private Limited , Avammune Lifesciences Private Limited | Director |
| Rohan Hemant Kamat | 06967484 | Straximm Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Aditya Kulkarni
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aditya Kulkarni
Aditya Kulkarni currently holds 4 directorships: Aten Porus Lifesciences Private Limited (Managing Director, since 25 Jul 2013, revenue ₹2.69 Cr (FY 2024)); Aten Biotech Private Limited (Managing Director, since 01 Jun 2013, revenue ₹28.9 Lakh (FY 2023)); Avammune Lifesciences Private Limited (Director, since 08 Nov 2024); Straximm Llp (Designated Partner, since 20 Dec 2017).
Aditya Kulkarni was first appointed on 01 Jun 2013 as Managing Director at Aten Biotech Private Limited. The most recent appointment on record is 08 Nov 2024 at Avammune Lifesciences Private Limited.
The 2 current companies of Aditya Kulkarni that report revenue have a combined latest revenue of ₹2.98 Cr: Aten Porus Lifesciences Private Limited ₹2.69 Cr (FY 2024); Aten Biotech Private Limited ₹28.9 Lakh (FY 2023).
Aditya Kulkarni held 1 earlier board appointment: Straximm Therapeutics Private Limited (Director, from 20 Apr 2018).
The current boards of Aditya Kulkarni's companies include Arun Bellandur Papaiah (Aten Porus Lifesciences Private Limited), Namala Srinivasan (Aten Porus Lifesciences Private Limited), Rohan Hemant Kamat (Straximm Llp).